Home
Price T Rowe Associates reported a 8.6% stake in Atrium Therapeutics RNA · 1,472,984 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.6%
- Last report
- 10% · filed 26/04/08
- Shares held
- 1,472,984 sh
- Class
- COMMON STOCK
- Holder
- Price T Rowe Associates
- Event date
- 26/06/30
- Filed
- 26/08/14
8.6% stake · −1.4pp from the last report
- Stake
- 8.6%
- Last report
- 10%
- Since last report
- −1.4pp
Atrium Therapeutics trades, last 26 weeks
What else happened in Atrium Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Price T Rowe Associates's other 5% stake reports
- Price T Rowe Associates
5% stake10x Genomics
5% stake10x Genomics
TXG
11.7% stake
14,044,020 sh
11.7% stake
Filed 09/08
- Price T Rowe Associates
5% stakePerrigo
5% stakePerrigo
PRGO
0.1% stake
231,010 sh
0.1% stake
Filed 09/08
- Price T Rowe Associates
5% stakeVicor
5% stakeVicor
VICR
12.8% stake
4,384,882 sh
12.8% stake
Filed 09/08
- Price T Rowe Associates
5% stakeKymera Therapeutics
5% stakeKymera Therapeutics
KYMR
10.7% stake
8,873,588 sh
10.7% stake
Filed 09/08
- Price T Rowe Associates
5% stakeMidera Food Processing
5% stakeMidera Food Processing
MFP
8.7% stake
3,940,556 sh
8.7% stake
Filed 09/08
